Cited by 667Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Insulin Analogues

Hirsch, Irl B.·2005·New England Journal of Medicine

DOI 10.1056/nejmra040832

Open this paper in CoChat — free account

Abstract

In the 1990s, the value of glycemic control in the management of diabetes became incontrovertible. The interest in producing insulin formulations that are safer than previous formulations and that more closely duplicate the basal and mealtime components of endogenous insulin secretion has yielded insulin analogues with action profiles that afford more flexible treatment regimens and a lower risk of hypoglycemia. This article examines the use of these newer insulins in clinical practice.

Integrity signals

Registry

Crossref · 10.1056/nejmra040832

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Untitled work
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818
Intermittent High Glucose Enhances Apoptosis Related to Oxidative Stress in Human Umbilical Vein Endothelial Cells
Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 772
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Standards of Medical Care in Diabetes
(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 688
Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
Yki‐Järvinen, H., Dressler, A., Ziemen, M., & HOE 901/300s Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1130 · Cited by 573
Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review
DeWitt, D. E., & Hirsch, I. B. (2003) · JAMA · doi:10.1001/jama.289.17.2254 · Cited by 502
Self-citation
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483

Show all 62 references

Sorted by citations

Items 201–300 of 667

Once-Daily Insulin Glargine Versus 6-Hour Sliding Scale Regular Insulin for Control of Hyperglycemia after a Bariatric Surgical Procedure: A Randomized Clinical Trial
Datta, S., Qaadir, A., Villanueva, G., & Baldwin, D. (2007) · Endocrine Practice · doi:10.4158/ep.13.3.225 · Cited by 31
Basal Plus Basal–Bolus Approach in Type 2 Diabetes
Ampudia‐Blasco, F. J., Rossetti, P., & Ascaso, J. F. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0001 · Cited by 30
7-Fluorosialyl Glycosides Are Hydrolysis Resistant but Readily Assembled by Sialyltransferases Providing Easy Access to More Metabolically Stable Glycoproteins
Geissner, A., Baumann, L., Morley, T., Wong, A., Sim, L., Rich, J. R., So, P. P. L., Dullaghan, E. M., Lessard, É., Iqbal, U., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01589 · Cited by 20
Transplant-associated hyperglycemia
Bloom, R. D., & Crutchlow, M. F. (2007) · Transplantation Reviews · doi:10.1016/j.trre.2007.06.001 · Cited by 30
Safety of insulin analogues as compared with human insulin in pregnancy
Toledano, Y., Hadar, E., & Hod, M. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1182153 · Cited by 30
Supramolecular Protein Engineering
Phillips, N. B., Wan, Z., Whittaker, L. J., Hu, S.-Q., Huang, K., Hua, Q. X., Whittaker, J., Ismail‐Beigi, F., & Weiss, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.105825 · Cited by 29
Evidence-based insulin treatment in type 1 diabetes mellitus
Jacobsen, I. B., Henriksen, J. E., Nielsen, O. H., Vach, W., & Beck‐Nielsen, H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.05.020 · Cited by 29
Aromatic Anchor at an Invariant Hormone-Receptor Interface
Pandyarajan, V., Smith, B. J., Phillips, N. B., Whittaker, L. J., Cox, G. P., Wickramasinghe, N. P., Menting, J. G. T., Wan, Z., Whittaker, J., Ismail‐Beigi, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608562 · Cited by 30
Equivalent Recombinant Human Insulin Preparations and their Place in Therapy
SANDOW, J., Landgraf, W., Becker, R. H. A., Seipke, G., & Chemistry and Biotechnology Development, S.-A. (2015) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2015.11.01.10 · Cited by 29
Pharmacological Management of Gestational Diabetes Mellitus
Mukerji, G., & Feig, D. S. (2017) · Drugs · doi:10.1007/s40265-017-0807-0 · Cited by 32
Pharmacotherapy for hyperglycemia in pregnancy – The new insulins
Toledano, Y., Hadar, E., & Hod, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.035 · Cited by 31
The Great Debate: Medicine or Surgery
Lautz, D. B., Halperin, F., GOEBEL-FABBRI, A. E., & Goldfine, A. B. (2011) · Diabetes Care · doi:10.2337/dc10-1859 · Cited by 28
Extending Halogen-based Medicinal Chemistry to Proteins
Hage, K. E., Pandyarajan, V., Phillips, N. B., Smith, B. J., Menting, J. G. T., Whittaker, J., Lawrence, M. C., Meuwly, M., & Weiss, M. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761015 · Cited by 28
Review of Insulin-Dependent and Insulin-Independent Agents for Treating Patients With Type 2 Diabetes Mellitus and Potential Role for Sodium-Glucose Co-Transporter 2 Inhibitors
Freeman, J. S. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.05.2672 · Cited by 27
The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine
Pieralli, F., Bazzini, C., Fabbri, A., Casati, C., Crociani, A., Corradi, F., Pignone, A. M., Morettini, A., & Nozzoli, C. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1358-6 · Cited by 28
Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
Martin, C., Criego, A. B., Carlson, A. L., & Bergenstal, R. M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1177-7 · Cited by 30
Management of Diabetes-related Hypoglycemia
Boyle, P. J., & Zrebiec, J. F. (2007) · Southern Medical Journal · doi:10.1097/01.smj.0000242864.17631.a2 · Cited by 28
Inpatient insulin therapy
Braithwaite, S. S. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f827e7 · Cited by 27
Use of antidiabetic drugs in elderly patients
Doucet, J. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(05)73658-2 · Cited by 27
Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy
Rakel, R. E. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0061-2 · Cited by 26
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)
Lind, M., Polonsky, W. H., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Pehrsson, N.-G., & Moström, P. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816642578 · Cited by 27
Self-citation
Why, when and how to initiate insulin therapy in patients with type 2 diabetes
Tibaldi, J. M., & Rakel, R. E. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01309.x · Cited by 27
Kinetic Modeling of Human Hepatic Glucose Metabolism in Type 2 Diabetes Mellitus Predicts Higher Risk of Hypoglycemic Events in Rigorous Insulin Therapy
König, M., & Holzhütter, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382069 · Cited by 27
Insulin detemir in the treatment of type 1 and type 2 diabetes
Philips, J., & Scheen, A. J. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.277 · Cited by 27
Glargine insulin for treatment of naturally occurring diabetes mellitus in dogs
Hess, R. S., & Drobatz, K. J. (2013) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.243.8.1154 · Cited by 27
Comparison of Once-Daily Glargine Insulin with Twice-Daily NPH/Regular Insulin for Control of Hyperglycemia in Inpatients After Cardiovascular Surgery
Yeldandi, R. R., Lurie, A., & Baldwin, D. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.609 · Cited by 27
Improved Postprandial Glycemic Control in Patients with Type 2 Diabetes from Subcutaneous Injection of Insulin Lispro with Hyaluronidase
Hompesch, M., Muchmore, D. B., Morrow, L., Ludington, E., & Vaughn, D. E. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0117 · Cited by 25
Insulin Therapy in Diabetes Mellitus
Bell, D. S. H. (2007) · Drugs · doi:10.2165/00003495-200767130-00002 · Cited by 26
Safety and side effects of the insulin analogues
Kamal, A. D., Dixon, A., & Bain, S. C. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.1.131 · Cited by 26
Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of Patients With Pancreatic Carcinoma Are Not Altered by Insulin Glargine
Erbel, S., Reers, C., Eckstein, V., Kleeff, J. H., Büchler, M. W., Nawroth, P. P., & Ritzel, R. A. (2008) · Diabetes Care · doi:10.2337/dc07-2015 · Cited by 26
The 600-Step Program for Type 1 Diabetes Self-Management in Youth: The Magnitude of the Self-Management Task
Coffen, R. D. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.09.2059 · Cited by 30
Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy
Cammarota, S., Bruzzese, D., Catapano, A. L., Citarella, A., de Luca, L., Manzoli, L., Masulli, M., Menditto, E., Mezzetti, A., Riegler, S., et al. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.04.002 · Cited by 26
Suicide and Self-inflicted Injury in Diabetes: A Balancing Act
Barnard-Kelly, K. D., Naranjo, D. M., Majidi, S., Aktürk, H. K., Breton, M. D., Courtet, P., Olié, É., Lal, R., Johnson, N., & Renard, É. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819891136 · Cited by 29
Cleveland Clinic Cardiovascular Intensive Care Unit Insulin Conversion Protocol
Olansky, L., Sam, S., Lober, C., Yared, J., & Hoogwerf, B. J. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300311 · Cited by 25
Diabetes screening, diagnosis, and therapy in pediatric patients with type 2 diabetes.
Rodbard, H. W. (2008) · PubMed Central · Cited by 24
Insulin Glulisine: An Evaluation of Its Pharmacodynamic Properties and Clinical Application
Helms, K. L., & Kelley, K. W. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1e662 · Cited by 25
The Future of Basal Insulin
Shah, V. N., Moser, E. G., Blau, A., Dhingra, M., & Garg, S. K. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0228 · Cited by 25
Ultrahigh Enzyme Loading Metal–Organic Frameworks for Deep Tissue Pancreatic Cancer Photoimmunotherapy
Liu, Q., Wang, L., Su, Y., Dong, W. X., Wang, H., Liu, Y., Liu, H., Liu, L., & Wang, Y. (2023) · Small · doi:10.1002/smll.202305131 · Cited by 24
Biophysical Optimization of a Therapeutic Protein by Nonstandard Mutagenesis
Pandyarajan, V., Phillips, N. B., Cox, G. P., Yang, Y., Whittaker, J., Ismail‐Beigi, F., & Weiss, M. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.588277 · Cited by 24
Glucose Levels at the Site of Subcutaneous Insulin Administration and Their Relationship to Plasma Levels
Lindpointner, S., Korsatko, S., Köhler, G., Kohler, H. J., Schaller, R., Schaupp, L. A., Ellmerer, M., Pieber, T. R., & Regittnig, W. (2010) · Diabetes Care · doi:10.2337/dc09-1531 · Cited by 24
Randomized Forced Titration to Different Doses of Technosphere® Insulin Demonstrates Reduction in Postprandial Glucose Excursions and Hemoglobin A1c in Patients with Type 2 Diabetes
Tack, C. J., Christov, V. G., de Galan, B. E., Derwahl, K.-M., Klausmann, G., Pelikánová, T., Perušičová, J., Boss, A., Amin, N., Kramer, D., et al. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200108 · Cited by 24
iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes
Hinnen, D., & Strong, J. L. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0014 · Cited by 24
Insulin Analogues in the Treatment of Diabetes in Pregnancy
Singh, C., & Jovanovič, L. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.03.003 · Cited by 24
Diabetes: advances in treatment
Cohen, N. D., & Shaw, J. E. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01369.x · Cited by 24
The closed‐loop artificial pancreas in 2020
Fabris, C., & Kovatchev, B. P. (2020) · Artificial Organs · doi:10.1111/aor.13704 · Cited by 23
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes
Švehlíková, E., Mursic, I., Augustin, T., Magnes, C., GERRING, D. J., Jezek, J., Schwarzenbacher, D., Ratzer, M., Wolf, M., Howell, S. J., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1017 · Cited by 26
The need for better insulin therapy
Grunberger, G. (2013) · Diabetes, obesity and metabolism · doi:10.1111/dom.12061 · Cited by 26
Insulin analogues in pregnancy and specific congenital anomalies: a literature review
de Jong, J., Garne, E., Wender-Ożegowska, E., Morgan, M., den Berg, L. T. W. D. J., & Wang, H. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2730 · Cited by 23
Insulin analogues use in pregnancy among women with pregestational diabetes mellitus and risk of congenital anomaly: a retrospective population-based cohort study
Wang, H., Wender-Ożegowska, E., Garne, E., Morgan, M., Loane, M. A., Morris, J. K., Bakker, M. K., Gatt, M., de Walle, H. E. K., Jordan, S., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2016-014972 · Cited by 24
Physiological and Behavioral Aspects of Glycemic Control and Hypoglycemia in Diabetes
Boyle, P. J., & Zrebiec, J. F. (2007) · Southern Medical Journal · doi:10.1097/01.smj.0000242866.81791.70 · Cited by 21
Current and Emerging Treatment Options in Diabetes Care
Clemmensen, C., Müller, T. D., Finan, B., Tschöp, M. H., & DiMarchi, R. D. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_7 · Cited by 22
Moderate intensity exercise in hypoxia increases IGF-1 bioavailability and serum irisin in individuals with type 1 diabetes
Żebrowska, A., Sikora, M., Konarska-Rawluk, A., Zwierzchowska, A., Kamiński, T., Robins, A., & Hall, B. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820925326 · Cited by 24
Basal insulin analogs: From pathophysiology to therapy. What we see, know, and try to comprehend?
Monnier, L., Colette, C., & Owens, D. R. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.09.003 · Cited by 22
Management of Diabetes in Patients Undergoing Bariatric Surgery
Mulla, C. M., Baloch, H. M., & Hafida, S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1242-2 · Cited by 24
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
Attri, B., Goyal, A., Gupta, Y., & Tandon, N. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00873-3 · Cited by 22
Diabetes Technology During the Past 30 Years: A Lot of Changes and Mostly for the Better
Deeb, L. C. (2008) · Diabetes Spectrum · doi:10.2337/diaspect.21.2.78 · Cited by 22
A evolução da insulinoterapia no diabetes melito tipo 1
Pires, A. C., & Chacra, A. R. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200014 · Cited by 21
Insulin Therapy in the Elderly Patient With Diabetes
Tanwani, L. K. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.02.006 · Cited by 20
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Candido, R., Wyne, K. L., & Romoli, E. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0422-4 · Cited by 22
The Transition from Insulin Infusions to Long-Term Diabetes Therapy: The Argument for Insulin Analogs
Braithwaite, S. S. (2006) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2007.01.005 · Cited by 20
Induction of immune tolerance to facilitate β cell regeneration in type 1 diabetes
Pasquali, L., Giannoukakis, N., & Trucco, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.032 · Cited by 21
Pharmacotherapy for gestational diabetes
Patti, A. M., Giglio, R. V., Pafili, K., Rizzo, M., & Papanas, N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1509955 · Cited by 19
“Pruning of biomolecules and natural products (PBNP)”: an innovative paradigm in drug discovery
Bathula, S. R., Murthy, A. S., Mainkar, P. S., & Chandrasekhar, S. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00403a · Cited by 20
Impact of glucagon response on early postprandial glucose excursions irrespective of residual β‐cell function in type 1 diabetes: A cross‐sectional study using a mixed meal tolerance test
Ito, A., Horie, I., Miwa, M., Sako, A., Niri, T., Nakashima, Y., Shigeno, R., Haraguchi, A., Natsuda, S., Akazawa, S., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13486 · Cited by 19
Peptide Hormones in Medicine: A 100-Year History
Мартинович, В. П., & Baradzina, K. U. (2022) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162022020157 · Cited by 19
Insulin Therapy in Type 1 Diabetes
Stephens, E. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.016 · Cited by 21
Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient
Meneghini, L. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01816.x · Cited by 19
Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin
Luo, J., & Gellad, W. F. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1286-3 · Cited by 19
Current management of gestational diabetes mellitus
Menato, G., Bo, S., Signorile, A., Gallo, M., Cotrino, I., Poala, C. B., & Massobrio, M. (2007) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.3.1.73 · Cited by 19
Hypoglycemia in Diabetes
Cryer, P. E., & Arbeláez, A. M. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch35 · Cited by 19
Improved glycaemic control with reduced hypoglycaemic episodes and without weight gain using long-term modern premixed insulins in type 2 diabetes
Levit, S., Toledano, Y., & Wainstein, J. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02513.x · Cited by 18
Insulin Glargine: A Reevaluation of Rodent Carcinogenicity Findings
Stammberger, I., & Esserméant, L. (2012) · International Journal of Toxicology · doi:10.1177/1091581811431111 · Cited by 18
Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review
Giugliano, D., Maiorino, M. I., Bellastella, G., Chiodini, P., & Esposito, K. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.03.005 · Cited by 18
Diabetes management: optimizing roles for nurses in insulin initiation
Levich, B. (2011) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s16451 · Cited by 20
Concepts and clinical use of ultra-long basal insulin
Eliaschewitz, F. G., & Barreto, T. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0117-1 · Cited by 17
Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach
Fathi, A. E., Fabris, C., & Breton, M. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795895 · Cited by 18
Insulin analogs in the treatment of type II diabetes and future perspectives
Sebastian, S. A., Co, E. L., Mehendale, M., & Hameed, M. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101417 · Cited by 17
Pulsatile intravenous insulin therapy: The best practice to reverse diabetes complications?
Mirbolooki, M., Taylor, G. E., Knutzen, V. K., Scharp, D. W., Willcourt, R. J., & Lakey, J. R. T. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.02.042 · Cited by 17
Clinical Performance of a Device That Applies Local Heat to the Insulin Infusion Site: A Crossover Study
Freckmann, G., Pleus, S., Westhoff, A., Krinelke, L., Buhr, A., Jendrike, N. R. M., & Haug, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600215 · Cited by 16
Structural Lessons From the Mutant Proinsulin Syndrome
Dhayalan, B., Chatterjee, D., Chen, Y., & Weiss, M. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.754693 · Cited by 20
Conjugation of ATIII‐Binding Pentasaccharides to Extend the Half‐Life of Proteins: Long‐Acting Insulin
de Kort, M., Gianotten, B., Wisse, J. A. J., Bos, E. S., Eppink, M. H. M., Mattaar, E., Vogel, G. M. T., Dokter, W. H. A., Honing, M., Vonsovic, S., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800053 · Cited by 17
Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus
Ersoy, A., Ersoy, C., & Altinay, T. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi205 · Cited by 17
Importance of Insulin Immunoassays in the Diagnosis of Factitious Hypoglycemia
Nalbantoğlu, Ö., Demir, K., Soylu, N., Çelik, N., & Özkan, B. (2014) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1492 · Cited by 17
Therapie des Diabetes mellitus Typ 2
Wiegand, S. (2005) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-005-1234-y · Cited by 17
The Artificial Pancreas: A Dynamic Challenge
Stavdahl, Ø., Fougner, A. L., Kölle, K., Christiansen, S. C., Ellingsen, R., & Carlsen, S. M. (2016) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2016.07.280 · Cited by 17
Technosphere®/Insulin
Leone‐Bay, A., & GRANT, M. L. (2008) · CRC Press eBooks · doi:10.3109/9781420045260-51 · Cited by 15
A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus
Liu, M., Zhou, Z., Yan, J., Li, P., Song, W., Fu, J., Chen, X., Zhao, W., Xi, L., Luo, X., et al. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0146-2 · Cited by 16
Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF
Yatuv, R., Robinson, M., Dayan, I., & Baru, M. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903463846 · Cited by 16
14-Day In Vitro Chemical Stability of Insulin Lispro in the MiniMed Paradigm Pump
Sharrow, S. D., Glass, L. C., & Dobbins, M. A. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0125 · Cited by 16
Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes
Moghissi, E. S., & FACE (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20071 · Cited by 16
Therapeutic management of posttransplant diabetes mellitus
Mannon, R. B. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2007.12.003 · Cited by 15
Identification of common key genes and pathways between Covid-19 and lung cancer by using protein-protein interaction network analysisPreprint
Nan, K. S., Karuppanan, K., & Kumar, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.16.431364 · Cited by 16
Proliferative and signaling activities of insulin analogues in endometrial cancer cells
Aizen, D., Sarfstein, R., Bruchim, I., Weinstein, D., Laron, Z., & Werner, H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.011 · Cited by 16
Activation of human insulin by vitamin E: A molecular dynamics simulation study
Soleymani, H., Ghorbani, M., Allahverdi, A., Shojaeilangari, S., & Naderi‐Manesh, H. (2019) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2019.06.006 · Cited by 15
Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells
Jeevanandam, J., Chan, Y. S., Danquah, M. K., & Law, M. C. (2019) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-019-03166-z · Cited by 15
Diabetes/Syndrome X
Schmeltz, L. R., & Metzger, B. E. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00179-6 · Cited by 16
Targeting prandial hyperglycemia: How important is it and how best to do this?
Monnier, L., & Colette, C. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0064-4 · Cited by 15
IDegAsp: a novel soluble insulin analogs combination
Ma, Z., Parkner, T., Christiansen, J. S., & Laursen, T. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.722203 · Cited by 15
Outcomes of glycemic control in type 1 diabetic patients switched from basal insulin glargine 100 U/ml to glargine 300 U/ml in real life
Oriot, P., Jérémie, W., & Buysschaert, M. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1469405 · Cited by 15
Exposure to insulin degludec during pregnancy: report of a small series and review of the literature
Bonora, B. M., Avogaro, A., & Fadini, G. P. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0926-9 · Cited by 15

Authors: Hirsch, I. B.
Affiliations: University of Washington (US)
Corresponding author: Hirsch, Irl B.
ORCID: Hirsch, Irl B.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-01-13
Volume: 352
Issue: 2
Pages: 174-183
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra040832
OpenAlex: W4242554702
Cited by: 667
References: 62
Citations by year: 2026: 13 · 2025: 8 · 2024: 14 · 2023: 11 · 2022: 23 · 2021: 16 · 2020: 26 · 2019: 19 · 2018: 31 · 2017: 29 · 2016: 36 · 2015: 36 · 2014: 27 · 2013: 39 · 2012: 46
FWCI: 5.86
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: insulin analogues, glycemic control, diabetes mellitus, hypoglycemia risk, insulin formulations
MeSH terms: Insulin Glargine, Child, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Drug Administration Schedule, Female, Humans, Hypoglycemic Agents, Insulin, Pregnancy, Blood Glucose Self-Monitoring, Insulin, Long-Acting, Insulin Aspart, Insulin Lispro

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Insulin Analogues

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks